Mulay James

SEC Form 4 insider trading activity

Mulay James has filed 9 SEC Form 4 filings (29 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jul 14, 2026.

On the most recent filing, Mulay James is listed as Director at CG Oncology, Inc. Inside the rolling window, Mulay James reported no open-market purchases and 10 open-market sales totaling $6.3M in CGON. The largest disclosed transaction in the window is a sale of 24,165 CGON shares on Jul 10, 2026, worth $1.8M.

Companies traded

Other insiders at CGON

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CGONSale$1.8MJul 14SEC ↗
CGONSale$118KJun 16SEC ↗
CGONSale$1.1MApr 20SEC ↗
CGONSale$125KMar 17SEC ↗
CGONSale$585KJan 13SEC ↗
CGONSale$260KOct 10SEC ↗
CGONSale$500KSep 30SEC ↗
CGONSale$746KSep 22SEC ↗
CGONSale$139KSep 22SEC ↗
CGONSale$852KSep 8SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Mulay James made?

Mulay James has filed 9 SEC Form 4 filings (29 transaction rows) across 1 company since 2025.

Which companies does Mulay James trade?

Mulay James has filed SEC Form 4 disclosures for 1 company, including CGON.

When was Mulay James's most recent SEC Form 4 filing?

Mulay James's most recent SEC Form 4 filing on Tracefour is dated Jul 14, 2026.

What is Mulay James's total buy and sell value in the current window?

Inside the rolling retention window, Mulay James bought $0 and sold $6.3M based on SEC Form 4 filings.

What was Mulay James's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 24,165 CGON shares on 2026-07-10, worth $1.8M, per SEC Form 4 filings.